Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Rapaport

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Biological Psychiatry|November 15, 1991
Haloperidol and soluble interleukin-2 receptorsM H Rapaport, A R Doran, D L Nelson, et al.
Molecular Psychiatry|March 25, 2015
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept studyM H Rapaport, A A Nierenberg, P J Schettler, et al.
Biological Psychiatry|April 1, 1988
Neuroendocrine effects of intravenous ovine corticotropin-releasing factor in affective disorder patients and normal controlsS C Risch, S Golshan, M H Rapaport, et al.
Archives of General Psychiatry|March 20, 2001
Sleep and sleep electroencephalogram in depressed patients treated with phenelzineH P Landolt, E B Raimo, B J Schnierow, et al.
International Clinical Psychopharmacology|December 23, 1998
A comparison of descriptive characteristics of male outpatients and inpatients with affective disordersM V Mendlowicz, M H Rapaport, P Thompson, et al.
Archives of General Psychiatry|October 1, 1989
Increased numbers of CD5+ B lymphocytes in schizophrenic patientsC G McAllister, M H Rapaport, D Pickar, et al.
General Hospital Psychiatry|April 15, 2000
Mothers murdering their newborns in the hospitalM V Mendlowicz, J F da Silva Filho, M Gekker, et al.
Journal of Affective Disorders|March 10, 2000
Quality of well being in panic disorder: the assessment of psychiatric and general disabilityH C Rubin, M H Rapaport, B Levine, et al.
Journal of Psychiatric Research|June 27, 2000
Sociodemographic predictors of temperament and characterM V Mendlowicz, G Jean-Louis, J C Gillin, et al.
Journal of Clinical Psychopharmacology|March 29, 2001
Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorderJ A Gladsjo, M H Rapaport, R McKinney, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Biological Psychiatry|November 15, 1991
Haloperidol and soluble interleukin-2 receptorsM H Rapaport, A R Doran, D L Nelson, et al.
Molecular Psychiatry|March 25, 2015
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept studyM H Rapaport, A A Nierenberg, P J Schettler, et al.
Biological Psychiatry|April 1, 1988
Neuroendocrine effects of intravenous ovine corticotropin-releasing factor in affective disorder patients and normal controlsS C Risch, S Golshan, M H Rapaport, et al.
Archives of General Psychiatry|March 20, 2001
Sleep and sleep electroencephalogram in depressed patients treated with phenelzineH P Landolt, E B Raimo, B J Schnierow, et al.
International Clinical Psychopharmacology|December 23, 1998
A comparison of descriptive characteristics of male outpatients and inpatients with affective disordersM V Mendlowicz, M H Rapaport, P Thompson, et al.
Archives of General Psychiatry|October 1, 1989
Increased numbers of CD5+ B lymphocytes in schizophrenic patientsC G McAllister, M H Rapaport, D Pickar, et al.
General Hospital Psychiatry|April 15, 2000
Mothers murdering their newborns in the hospitalM V Mendlowicz, J F da Silva Filho, M Gekker, et al.
Journal of Affective Disorders|March 10, 2000
Quality of well being in panic disorder: the assessment of psychiatric and general disabilityH C Rubin, M H Rapaport, B Levine, et al.
Journal of Psychiatric Research|June 27, 2000
Sociodemographic predictors of temperament and characterM V Mendlowicz, G Jean-Louis, J C Gillin, et al.
Journal of Clinical Psychopharmacology|March 29, 2001
Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorderJ A Gladsjo, M H Rapaport, R McKinney, et al.
Pageof 9